1. Home
  2. MRUS vs BGC Comparison

MRUS vs BGC Comparison

Compare MRUS & BGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRUS
  • BGC
  • Stock Information
  • Founded
  • MRUS 2003
  • BGC 1945
  • Country
  • MRUS Netherlands
  • BGC United States
  • Employees
  • MRUS N/A
  • BGC N/A
  • Industry
  • MRUS Biotechnology: Pharmaceutical Preparations
  • BGC Investment Bankers/Brokers/Service
  • Sector
  • MRUS Health Care
  • BGC Finance
  • Exchange
  • MRUS Nasdaq
  • BGC Nasdaq
  • Market Cap
  • MRUS 5.1B
  • BGC 4.4B
  • IPO Year
  • MRUS 2016
  • BGC 1999
  • Fundamental
  • Price
  • MRUS $96.19
  • BGC $8.70
  • Analyst Decision
  • MRUS Buy
  • BGC Strong Buy
  • Analyst Count
  • MRUS 17
  • BGC 2
  • Target Price
  • MRUS $94.94
  • BGC $14.50
  • AVG Volume (30 Days)
  • MRUS 1.3M
  • BGC 3.1M
  • Earning Date
  • MRUS 10-31-2025
  • BGC 11-06-2025
  • Dividend Yield
  • MRUS N/A
  • BGC 0.92%
  • EPS Growth
  • MRUS N/A
  • BGC 36.46
  • EPS
  • MRUS N/A
  • BGC 0.33
  • Revenue
  • MRUS $56,606,000.00
  • BGC $2,640,884,000.00
  • Revenue This Year
  • MRUS $52.81
  • BGC $35.74
  • Revenue Next Year
  • MRUS N/A
  • BGC $11.43
  • P/E Ratio
  • MRUS N/A
  • BGC $26.35
  • Revenue Growth
  • MRUS 57.54
  • BGC 24.59
  • 52 Week Low
  • MRUS $33.19
  • BGC $7.24
  • 52 Week High
  • MRUS $96.28
  • BGC $10.96
  • Technical
  • Relative Strength Index (RSI)
  • MRUS 72.69
  • BGC 42.33
  • Support Level
  • MRUS $95.74
  • BGC $8.27
  • Resistance Level
  • MRUS $96.18
  • BGC $9.35
  • Average True Range (ATR)
  • MRUS 0.36
  • BGC 0.22
  • MACD
  • MRUS -0.39
  • BGC -0.02
  • Stochastic Oscillator
  • MRUS 89.43
  • BGC 40.19

About MRUS Merus N.V.

Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only one reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.

About BGC BGC Group Inc.

BGC Group Inc is a brokerage and financial technology company that serves financial markets, energy, and commodities markets. Its service and product offerings include brokerage for a wide range of financial products, including fixed income, equities, commodities, derivatives, and real estate, software solutions for trading platforms, clearing, trade execution, and other back-office services. Its clients mostly include banks, financial institutions, and corporate clients. BGC operates in one reportable segment, which is providing brokerage services. Geographically, the company generates a majority of its revenue from Europe, Middle East and Africa (EMEA), followed by the Americas and the Asia-Pacific region.

Share on Social Networks: